FDA Inspection 981968 — Zhejiang Kangle Pharmaceutical Co., Ltd (Binhai Plant)

Zhejiang Kangle Pharmaceutical Co., Ltd (Binhai Plant) — FEI 3010728912

The FDA completed an inspection of Zhejiang Kangle Pharmaceutical Co., Ltd (Binhai Plant) on July 22, 2016 in Wenzhou. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
July 22, 2016
Fiscal Year
2016
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Wenzhou (China)